BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25902152)

  • 1. Regulation of endogenous transmembrane receptors through optogenetic Cry2 clustering.
    Bugaj LJ; Spelke DP; Mesuda CK; Varedi M; Kane RS; Schaffer DV
    Nat Commun; 2015 Apr; 6():6898. PubMed ID: 25902152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optogenetic protein clustering through fluorescent protein tagging and extension of CRY2.
    Park H; Kim NY; Lee S; Kim N; Kim J; Heo WD
    Nat Commun; 2017 Jun; 8(1):30. PubMed ID: 28646204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light-Regulated Protein Kinases Based on the CRY2-CIB1 System.
    Mühlhäuser WW; Hörner M; Weber W; Radziwill G
    Methods Mol Biol; 2017; 1596():257-270. PubMed ID: 28293892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optogenetic Control of Fibroblast Growth Factor Receptor Signaling.
    Kim N; Kim JM; Heo WD
    Methods Mol Biol; 2016; 1408():345-62. PubMed ID: 26965135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in optogenetic regulation of gene expression in mammalian cells using cryptochrome 2 (CRY2).
    Hernández-Candia CN; Wysoczynski CL; Tucker CL
    Methods; 2019 Jul; 164-165():81-90. PubMed ID: 30905749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatiotemporal control of fibroblast growth factor receptor signals by blue light.
    Kim N; Kim JM; Lee M; Kim CY; Chang KY; Heo WD
    Chem Biol; 2014 Jul; 21(7):903-12. PubMed ID: 24981772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein Inactivation by Optogenetic Trapping in Living Cells.
    Park H; Lee S; Heo WD
    Methods Mol Biol; 2016; 1408():363-76. PubMed ID: 26965136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Spatiotemporal Manipulation of Signaling Perturbations Using Optogenetics.
    Valon L; Etoc F; Remorino A; di Pietro F; Morin X; Dahan M; Coppey M
    Biophys J; 2015 Nov; 109(9):1785-97. PubMed ID: 26536256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized light-inducible transcription in mammalian cells using Flavin Kelch-repeat F-box1/GIGANTEA and CRY2/CIB1.
    Quejada JR; Park SE; Awari DW; Shi F; Yamamoto HE; Kawano F; Jung JC; Yazawa M
    Nucleic Acids Res; 2017 Nov; 45(20):e172. PubMed ID: 29040770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CL6mN: Rationally Designed Optogenetic Photoswitches with Tunable Dissociation Dynamics.
    Mukherjee A; Sudrik C; Hu Y; Arha M; Stathos M; Baek J; Schaffer DV; Kane RS
    ACS Synth Biol; 2020 Sep; 9(9):2274-2281. PubMed ID: 32794731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights into the photoactivation of Arabidopsis CRY2.
    Ma L; Guan Z; Wang Q; Yan X; Wang J; Wang Z; Cao J; Zhang D; Gong X; Yin P
    Nat Plants; 2020 Dec; 6(12):1432-1438. PubMed ID: 33199893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional approaches for optogenetic regulation of gene expression in mammalian cells using Arabidopsis cryptochrome 2.
    Pathak GP; Spiltoir JI; Höglund C; Polstein LR; Heine-Koskinen S; Gersbach CA; Rossi J; Tucker CL
    Nucleic Acids Res; 2017 Nov; 45(20):e167. PubMed ID: 28431041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Dual Characteristics of Light-Induced Cryptochrome 2, Homo-oligomerization and Heterodimerization, for Optogenetic Manipulation in Mammalian Cells.
    Che DL; Duan L; Zhang K; Cui B
    ACS Synth Biol; 2015 Oct; 4(10):1124-35. PubMed ID: 25985220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding CRY2 interactions for optical control of intracellular signaling.
    Duan L; Hope J; Ong Q; Lou HY; Kim N; McCarthy C; Acero V; Lin MZ; Cui B
    Nat Commun; 2017 Sep; 8(1):547. PubMed ID: 28916751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible optogenetic control of kinase activity during differentiation and embryonic development.
    Krishnamurthy VV; Khamo JS; Mei W; Turgeon AJ; Ashraf HM; Mondal P; Patel DB; Risner N; Cho EE; Yang J; Zhang K
    Development; 2016 Nov; 143(21):4085-4094. PubMed ID: 27697903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optogenetic Control of Gene Expression Using Cryptochrome 2 and a Light-Activated Degron.
    Hernández-Candia CN; Tucker CL
    Methods Mol Biol; 2020; 2173():151-158. PubMed ID: 32651916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optogenetic control of focal adhesion kinase signaling.
    Hörner M; Chatelle C; Mühlhäuser WWD; Stocker DR; Coats M; Weber W; Radziwill G
    Cell Signal; 2018 Jan; 42():176-183. PubMed ID: 29074139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized second-generation CRY2-CIB dimerizers and photoactivatable Cre recombinase.
    Taslimi A; Zoltowski B; Miranda JG; Pathak GP; Hughes RM; Tucker CL
    Nat Chem Biol; 2016 Jun; 12(6):425-30. PubMed ID: 27065233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optogenetic Approaches for the Spatiotemporal Control of Signal Transduction Pathways.
    Kramer MM; Lataster L; Weber W; Radziwill G
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optogenetic control of intracellular signaling pathways.
    Zhang K; Cui B
    Trends Biotechnol; 2015 Feb; 33(2):92-100. PubMed ID: 25529484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.